Inogen Inc (INGN)
7.97
+0.23
(+2.97%)
USD |
NASDAQ |
Mar 27, 16:00
7.96
-0.01
(-0.13%)
After-Hours: 20:00
Inogen Enterprise Value: 57.44M for March 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
March 27, 2024 | 57.44M |
March 26, 2024 | 52.08M |
March 25, 2024 | 46.95M |
March 22, 2024 | 36.45M |
March 21, 2024 | 37.62M |
March 20, 2024 | 32.25M |
March 19, 2024 | 31.32M |
March 18, 2024 | 31.08M |
March 15, 2024 | 32.48M |
March 14, 2024 | 28.98M |
March 13, 2024 | 38.08M |
March 12, 2024 | 34.35M |
March 11, 2024 | 39.25M |
March 08, 2024 | 48.58M |
March 07, 2024 | 47.41M |
March 06, 2024 | 35.52M |
March 05, 2024 | 28.98M |
March 04, 2024 | 27.35M |
March 01, 2024 | 35.40M |
February 29, 2024 | 26.65M |
February 28, 2024 | 18.25M |
February 27, 2024 | 89.40M |
February 26, 2024 | 88.00M |
February 23, 2024 | 85.90M |
February 22, 2024 | 86.49M |
Date | Value |
---|---|
February 21, 2024 | 86.95M |
February 20, 2024 | 89.24M |
February 16, 2024 | 101.63M |
February 15, 2024 | 104.39M |
February 14, 2024 | 66.76M |
February 13, 2024 | 54.83M |
February 12, 2024 | 71.35M |
February 09, 2024 | 59.88M |
February 08, 2024 | 45.20M |
February 07, 2024 | 47.72M |
February 06, 2024 | 42.21M |
February 05, 2024 | 25.47M |
February 02, 2024 | 24.32M |
February 01, 2024 | 38.31M |
January 31, 2024 | 34.76M |
January 30, 2024 | 16.86M |
January 29, 2024 | 9.179M |
January 26, 2024 | 2.296M |
January 25, 2024 | 0.9196M |
January 24, 2024 | -6.192M |
January 23, 2024 | -2.522M |
January 22, 2024 | -0.6863M |
January 19, 2024 | -5.733M |
January 18, 2024 | -6.307M |
January 17, 2024 | -5.275M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-50.93M
Minimum
Sep 25 2023
1.852B
Maximum
Mar 31 2019
593.54M
Average
504.38M
Median
Enterprise Value Benchmarks
Oragenics Inc | -0.0833M |
Palatin Technologies Inc | 16.33M |
Oramed Pharmaceuticals Inc | 3.112M |
vTv Therapeutics Inc | 53.05M |
G1 Therapeutics Inc | 202.73M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -26.56M |
Revenue (Quarterly) | 75.90M |
Total Expenses (Quarterly) | 104.88M |
EPS Diluted (Quarterly) | -1.14 |
Gross Profit Margin (Quarterly) | 37.10% |
Profit Margin (Quarterly) | -34.99% |
Earnings Yield | -55.33% |
Normalized Earnings Yield | -41.30 |